7-101163294-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003378.4(VGF):c.1550G>T(p.Arg517Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,134,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003378.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGF | NM_003378.4 | c.1550G>T | p.Arg517Leu | missense_variant | 2/2 | ENST00000249330.3 | NP_003369.2 | |
VGF | XM_005250561.6 | c.1550G>T | p.Arg517Leu | missense_variant | 2/2 | XP_005250618.1 | ||
VGF | XM_011516549.4 | c.1550G>T | p.Arg517Leu | missense_variant | 3/3 | XP_011514851.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGF | ENST00000249330.3 | c.1550G>T | p.Arg517Leu | missense_variant | 2/2 | 1 | NM_003378.4 | ENSP00000249330 | P1 | |
VGF | ENST00000445482.2 | c.1550G>T | p.Arg517Leu | missense_variant | 2/2 | 5 | ENSP00000400884 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000946 AC: 9AN: 95142Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.0000835 AC: 11AN: 131770Hom.: 0 AF XY: 0.0000962 AC XY: 7AN XY: 72788
GnomAD4 exome AF: 0.000164 AC: 171AN: 1039744Hom.: 0 Cov.: 36 AF XY: 0.000175 AC XY: 89AN XY: 509020
GnomAD4 genome AF: 0.0000946 AC: 9AN: 95142Hom.: 0 Cov.: 20 AF XY: 0.0000684 AC XY: 3AN XY: 43842
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | The c.1550G>T (p.R517L) alteration is located in exon 2 (coding exon 1) of the VGF gene. This alteration results from a G to T substitution at nucleotide position 1550, causing the arginine (R) at amino acid position 517 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at